Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


The interplay of CDK4 and CDK6 in melanoma.

Kollmann K, Briand C, Bellutti F, Schicher N, Blunder S, Zojer M, Hoeller C.

Oncotarget. 2019 Feb 15;10(14):1346-1359. doi: 10.18632/oncotarget.26515. eCollection 2019 Feb 15.


Cdk6: At the interface of Rb and p53.

Nebenfuehr S, Bellutti F, Sexl V.

Mol Cell Oncol. 2018 Sep 5;5(5):e1511206. doi: 10.1080/23723556.2018.1511206. eCollection 2018.


CDK6 Antagonizes p53-Induced Responses during Tumorigenesis.

Bellutti F, Tigan AS, Nebenfuehr S, Dolezal M, Zojer M, Grausenburger R, Hartenberger S, Kollmann S, Doma E, Prchal-Murphy M, Uras IZ, Höllein A, Neuberg DS, Ebert BL, Ringler A, Mueller AC, Loizou JI, Hinds PW, Vogl C, Heller G, Kubicek S, Zuber J, Malumbres M, Farlik M, Villunger A, Kollmann K, Sexl V.

Cancer Discov. 2018 Jul;8(7):884-897. doi: 10.1158/2159-8290.CD-17-0912. Epub 2018 Jun 13.


p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

Uras IZ, Bellutti F, Sexl V.

Haematologica. 2017 Aug;102(8):1299-1301. doi: 10.3324/haematol.2017.171819. No abstract available.


Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6.

Uras IZ, Walter GJ, Scheicher R, Bellutti F, Prchal-Murphy M, Tigan AS, Valent P, Heidel FH, Kubicek S, Scholl C, Fröhling S, Sexl V.

Blood. 2016 Jun 9;127(23):2890-902. doi: 10.1182/blood-2015-11-683581. Epub 2016 Apr 20.


CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Tigan AS, Bellutti F, Kollmann K, Tebb G, Sexl V.

Oncogene. 2016 Jun 16;35(24):3083-91. doi: 10.1038/onc.2015.407. Epub 2015 Oct 26. Review.


Identification of RISC-associated adenoviral microRNAs, a subset of their direct targets, and global changes in the targetome upon lytic adenovirus 5 infection.

Bellutti F, Kauer M, Kneidinger D, Lion T, Klein R.

J Virol. 2015 Feb;89(3):1608-27. doi: 10.1128/JVI.02336-14. Epub 2014 Nov 19.


CDK6 as a key regulator of hematopoietic and leukemic stem cell activation.

Scheicher R, Hoelbl-Kovacic A, Bellutti F, Tigan AS, Prchal-Murphy M, Heller G, Schneckenleithner C, Salazar-Roa M, Zöchbauer-Müller S, Zuber J, Malumbres M, Kollmann K, Sexl V.

Blood. 2015 Jan 1;125(1):90-101. doi: 10.1182/blood-2014-06-584417. Epub 2014 Oct 23. Erratum in: Blood. 2018 Aug 30;132(9):978-979.


Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis.

Rodríguez-Díez E, Quereda V, Bellutti F, Prchal-Murphy M, Partida D, Eguren M, Kollmann K, Gómez de Cedrón M, Dubus P, Cañamero M, Martínez D, Sexl V, Malumbres M.

Blood. 2014 Oct 9;124(15):2380-90. doi: 10.1182/blood-2014-02-555292. Epub 2014 Aug 25.


Monitoring cellular stress responses to nanoparticles using a lab-on-a-chip.

Richter L, Charwat V, Jungreuthmayer C, Bellutti F, Brueckl H, Ertl P.

Lab Chip. 2011 Aug 7;11(15):2551-60. doi: 10.1039/c1lc20256a. Epub 2011 Jun 17.


Supplemental Content

Loading ...
Support Center